Reclast Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Zoledronic Acid in Decrease the Lung Metastatic Rate of Osteosarcoma
Conditions:   Lung Metastases;   Tumor Necrosis Intervention:   Drug: Zoledronic Acid Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2019 Category: Research Source Type: clinical trials